Ipsen - David Meek appointed as Chief Executive Officer of Ipsen http://www. ipsen.com/wp-content/uploads/2016/07/11-07-2016-PR-David-Meek-new-CEO-of- Ipsen.pdf | Facebook
Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
Press Releases - Ipsen UK
06-01-2016-PR-Ipsen-Galderma-APAC-Dysport-Aesthetics
Ipsen Inc. | Aviation Pros
Ipsen (@IpsenGroup) / X
Ipsen is officially recognized as a great place to work worldwide - Global
Paul van Doesburg, CEO, Ipsen, Germany | The Monty
Press Releases / Melissa Peebles
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
Press Releases - Ipsen UK
Ipsen media library
Ipsen CEO steers clear of gene therapy despite rare disease push
Ipsen NHS Study Published - IFOPA - International Fibrodysplasia Ossificans Progressiva Association
Gebrüder Weiss takes over Ipsen Logistics' Air & Sea business | DC Velocity
Ipsen and Medetia join forces to accelerate early research in rare disease - Global
Press Releases - Ipsen UK
Ipsen: a dynamic, fast-growing specialty care powerhouse
Global Biopharmaceutical Company, Ipsen Announces New Headquarters for North America will be located in Cambridge, Massachusetts | Financial Post
LeaveRussia: Ipsen is Pausing New Investments in Russia
Combined Shareholders' Meeting of 27 May 2021
Ipsen: Patients Living with Spasticity Want Long-lasting Symptom Relief | Business Wire
Press releases
Press Releases - Ipsen UK
Ipsen Goes All In on Neuro with $1 Billion+ Deal For Exicure's Oligonucleotides | BioSpace
